Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Beta Blocker Therapy in Moderate to Severe COPD [Phase 4]
Phase 4 clinical trial update on beta blocker therapy in moderate to severe chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: The Use of High Frequency Oscillations With NIV in Hypercapnic COPD Participants [NA]
A terminated clinical trial evaluating high frequency oscillations with noninvasive ventilation in hypercapnic COPD participants has posted …
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Study of Danirixin in Japanese Healthy Elderly Male Subjects [Phase 1]
Phase 1 study of danirixin in Japanese healthy elderly male subjects completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Assessment of Reactance Parameters Measured by the Forced Oscillation Technique for the Bronchodilator Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 clinical trial investigating reactance parameters from forced oscillation technique to assess bronchodilator response in COPD patien…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)
Clinical trial update for OTIVACTO (tiotropium/olodaterol) in COPD assessing physical functioning and handling; study terminated with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Vitabreath Pilot in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
A completed pilot clinical trial for Vitabreath in COPD patients with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Does Extra-fine Hydrofluoroalkane-beclomethasone Dipropionate (HFA-BDP) Suppress Small Airways Inflammation in Chronic Obstructive Pulmonary Disease (COPD)? [Phase 4]
A Phase 4 trial investigating whether extra-fine HFA-beclomethasone dipropionate reduces small airway inflammation in COPD has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial assessing the effects of roflumilast on subclinical atherosclerosis in COPD; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Evaluation of Long-Acting Muscarinic Antagonists in COPD [Phase 4]
Phase 4 trial update evaluating long-acting muscarinic antagonists in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 clinical trial reporting differential trough effects of a triple therapy on pulmonary function in COPD.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD). [Phase 4]
Phase 4 trial comparing fluticasone furoate/vilanterol inhalation powder to vilanterol alone in COPD, focusing on bone mineral density outco…
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 trial updating dose response for inhaled fluticasone propionate in chronic obstructive pulmonary disease completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients [Phase 1]
Phase 1 trial examining the bioavailability of tiotropium + olodaterol fixed-dose combination in Chinese patients with chronic obstructive p…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep [Phase 4]
Phase 4 trial update comparing fluticasone-salmeterol in COPD, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort [Phase 4]
Phase 4 trial updating outcomes after switching symptomatic COPD patients from salmeterol/fluticasone to indacaterol/glycopyrronium.
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Absorption & Elimination of Radiolabelled GSK2269557 [Phase 1]
Phase 1 trial update on absorption and elimination of radiolabeled GSK2269557; results completed and posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD [Phase 3]
Phase 3 trial assessing PT003 and placebo on airway volumes and resistance in moderate-to-severe COPD; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen [Phase 4]
Phase 4 trial evaluating a fixed-dose combination of glycopyrronium and indacaterol/glycopyrronium bromide for COPD patients switching from …
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers [NA]
A completed COPD trial comparing nebulizers to dry powder inhalers; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Evaluating Forced Oscillation Technique (FOT) in Abolishing Flow Limitation [NA]
A completed clinical trial evaluating the Forced Oscillation Technique for addressing flow limitation in chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure [NA]
Clinical trial update for venovenous CO2 removal in COPD patients with acute respiratory failure; study terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations
A clinical trial evaluating vagus nerve stimulation for managing bronchoconstriction in COPD exacerbations was terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Improving Patient-Centered Care Delivery Among Patients With Chronic Obstructive Pulmonary Disease [NA]
Clinical trial update on improving patient-centered care delivery for chronic obstructive pulmonary disease; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Optimization of Pulmonary Rehabilitation Programmes: the OPTION Study [NA]
The OPTION study, examining optimization of pulmonary rehabilitation for COPD, has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Oral β-Alanine Supplementation in Patients With COPD [NA]
A clinical trial studying oral beta-alanine supplementation in chronic obstructive pulmonary disease has completed.